Exmoor Pharma

eXmoor Pharma is the only integrated UK cell and gene therapy CDMO with consultancy expertise embedded at every stage of your journey, from early-phase strategy through GMP manufacturing to commercialisation. For over 20 years, we have provided specialised CMC consulting, process development, and GMP clinical manufacturing to more than 170 clients. Our industry-leading scientists and strategists help biotech and pharma companies accelerate innovation while reducing risk and costs. Our purpose-built process development and GMP manufacturing facility offers end-to-end solutions across Viral Vectors, Autologous & Allogeneic Cell Therapies, and RNA Technologies. Unlike traditional CDMOs, we offer flexibility, full transparency, and IP freedom, ensuring you remain in control of your therapy’s future. Trusted by Industry Leaders Long-term partnerships define our success—70% of our clients return for ongoing collaboration. From academic innovators to biotech spin-outs and global pharma companies, we provide the expertise, infrastructure, and strategic foresight to transform groundbreaking science into life-changing therapies. Our Culture: Collaboration, Innovation, and Impact Much like our client relationships, our work culture is built on capability, collaboration, and trust. We create an environment where expertise thrives, encouraging innovation, continuous learning, and cross-functional teamwork. Our team works side by side, sharing knowledge and insights to drive the future of cell and gene therapy. Rooted in transparency, problem-solving, and scientific excellence, our culture empowers people to grow, lead, and make a meaningful impact in an evolving industry. Where Consultancy Leads and GMP Delivers. Your CGT CDMO Partner. To learn more about eXmoor Pharma, visit our website: and to join our team visit: